Avantax Advisory Services’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,494
Closed -$375K 2343
2024
Q4
$375K Sell
4,494
-24
-0.5% -$2K ﹤0.01% 1630
2024
Q3
$331K Buy
4,518
+94
+2% +$6.88K ﹤0.01% 1686
2024
Q2
$303K Buy
+4,424
New +$303K ﹤0.01% 1690